DA
GILD icon

Duality Advisers’s Gilead Sciences GILD Stock Holding History

Duality Advisers’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-72,177
Closed -$5.29M – 215
2024
Q1 		$5.29M Buy
+72,177
New +$5.55M 0.52% 30
2022
Q3 		– Sell
-7,758
Closed -$480K – 615
2022
Q2 		$480K Sell
7,758
-26,439
-77% -$1.64M 0.05% 471
2022
Q1 		$2.03M Buy
+34,197
New +$2.19M 0.22% 159
2020
Q4 		– Sell
-14,480
Closed -$915K – 619
2020
Q3 		$915K Sell
14,480
-4,238
-23% -$294K 0.06% 386
2020
Q2 		$1.44M Buy
+18,718
New +$1.43M 0.13% 208
2020
Q1 		– Sell
-66,528
Closed -$4.32M – 130
2019
Q4 		$4.32M Buy
+66,528
New +$4.33M 0.26% 137
2019
Q3 		– Sell
-136,670
Closed -$9.23M – 357
2019
Q2 		$9.23M Buy
+136,670
New +$8.99M 0.81% 29

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Duality Advisers's GILD Position: Q2 2024 in Review

Duality Advisers sold out of Gilead Sciences (GILD) in Q2 2024, closing a stake of 72,177 shares — an estimated $5.29M sold.

Duality Advisers first reported a position in GILD in Q2 2019 and held it in 7 quarters. The position peaked at $9.23M in Q2 2019. 1,678 funds tracked by Wall St. Rank hold GILD as of Q2 2024.

  • Duality Advisers reported no remaining Gilead Sciences position as of Q2 2024 after selling out during the quarter.
  • Duality Advisers sold 72,177 Gilead Sciences shares in Q2 2024, an estimated $5.29M.
  • Duality Advisers first reported a position in Gilead Sciences in Q2 2019 and held it in 7 quarters.
  • Duality Advisers's Gilead Sciences position peaked at $9.23M in Q2 2019.
  • 1,678 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.

Based on Duality Advisers's 13F filing for Q2 2024.